Cas 916442-66-5,4-(2-Bromo-4-trifluoromethyl-phenylcarbamoyl)-piperidine-1-carboxylic acid tert-butyl ester

916442-66-5

Post Buying Request

Basic information

Product Name: 4-(2-Bromo-4-trifluoromethyl-phenylcarbamoyl)-piperidine-1-carboxylic acid tert-butyl ester
Synonyms: 4-(2-Bromo-4-trifluoromethyl-phenylcarbamoyl)-piperidine-1-carboxylic acid tert-butyl ester
CAS NO:916442-66-5
Molecular Formula:
Molecular Weight: 451.283
EINECS: N/A
Product Categories: N/A
Mol File: 916442-66-5.mol
Article Data: 1

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 4-(2-Bromo-4-trifluoromethyl-phenylcarbamoyl)-piperidine-1-carboxylic acid tert-butyl ester(CAS DataBase Reference)
NIST Chemistry Reference: 4-(2-Bromo-4-trifluoromethyl-phenylcarbamoyl)-piperidine-1-carboxylic acid tert-butyl ester(916442-66-5)
EPA Substance Registry System: 4-(2-Bromo-4-trifluoromethyl-phenylcarbamoyl)-piperidine-1-carboxylic acid tert-butyl ester(916442-66-5)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 916442-66-5(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

916442-66-5 Suppliers

Recommended suppliersmore

916442-66-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 916442-66-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,1,6,4,4 and 2 respectively; the second part has 2 digits, 6 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 916442-66:
(8*9)+(7*1)+(6*6)+(5*4)+(4*4)+(3*2)+(2*6)+(1*6)=175
175 % 10 = 5
So 916442-66-5 is a valid CAS Registry Number.

916442-66-5Upstream product

916442-66-5Downstream Products

916442-66-5Relevant articles and documents

Novel 3-spirocyclic indolyl derivatives useful as ORL-1 receptor modulators

-

Page/Page column 16-17, (2010/11/27)

The present invention is directed to novel 3-spirocyclic indolyl derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by the ORL-1 receptor.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 916442-66-5